Company / Shares Outstanding
Stoke Therapeutics, Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
54.0M
FY2025
5-year range
36.7M / 54.0M
FY2021-FY2025
Trend
+17.7%
vs FY2024
Sector context
#158 of 212
Health Care
What the data says
Stoke Therapeutics, Inc.'s shares outstanding of 54032826.00 is lower than 75% of companies in the Health Care sector (FY2025). Shares Outstanding has increased for 7 consecutive years, from 709336.00 in FY2018 to 54032826.00 in FY2025.
Based on SEC 10-K filings.
54032826.00 in FY2025 with a 5-year CAGR of +10.0%.
Increased from 39439575.00 to 54032826.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- +10.0%
- 10-Year CAGR
- -
Sector benchmark
-82.4% below sector average
Key checks
Key Insights
- Stoke Therapeutics, Inc.'s shares outstanding has grown for 7 consecutive years.
- In FY2025, shares outstanding increased 17.7% year-over-year.
- Ranks #158 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 54.0M | +17.7% |
| FY2024 | 45.9M | +16.4% |
| FY2023 | 39.4M | +6.9% |
| FY2022 | 36.9M | +0.4% |
| FY2021 | 36.7M | +9.7% |
| FY2020 | 33.5M | +86.3% |
| FY2019 | 18.0M | +2433.6% |
| FY2018 | 709.3K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026